Nautilus Biotechnology, Inc.
NAUT • NASDAQ
Nautilus Biotechnology, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sujal Patel, with a market cap of $351.8M.
Market Cap$351.8M
Employees163.0
CEOSujal Patel
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsApr 28, 2026 · In 4 daysBefore Market Open · Q1 2026
Financials
Nautilus Biotechnology, Inc. FAQ
Common questions about Nautilus Biotechnology, Inc.
Nautilus Biotechnology, Inc. is scheduled to report earnings for Q1 2026 on April 28, 2026 before market open. Analysts estimate revenue of $250.0K.
Nautilus Biotechnology, Inc. has approximately 163 employees.